Genetics Flashcards

1
Q
  • Huntingtons disease, Marfans syndrome and Achondroplasia
  • An affected person has at least one affected parent.
  • Affects either sex.
  • Transmitted by either sex.
  • A child of an affected X/ unaffected mating has a 50% chance of being affected (this assumes that the affected person is heterozygous, which is usually true for rare conditions).
  • Only one bad gene is required to give the effect
    most dominant diseases are caused by the production of a “poison” product, an abnormal product or waste accumulation. in their presence the normal gene cannot compensate
    in order for these genes to be maintained within a population the diseases must be passed on- late onset e.g. huntingtons, reduced penetrance, variable expressivity.
A

Autosomal Dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cystic Fibrosis, sickle cell disease, Thalassaemias. PhenylPKU
- Affected people born to unaffected parents.
- Parents usually asymptomatic carriers.
often increased incidence of parental consanguinity.
- Affects either sex.
- only affects homozygote
- result in a decrease in the levels or activities of proteins.
- Heterozygotes may have half the protein or activity of “normals” and be clinically unaffected. In some diseases e.g. haemoglobinopathies heterozygotes may show mild symptoms

A

Autosomal recessive
2 carrier parents have 25% chance affected child.
Consanguinity ^ chance
Inborn errors of metabolism normal AR. Error in a gene coded for an enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  • Hemophila, colour blindness, muscular dystrophy
  • Affects almost exclusively males.
  • Affected males are usually born to unaffected parents; the mother is normally an asymptomatic carrier and may have affected male relatives.
  • Females may be affected if the father is affected and the mother is a carrier, or occasionally as a result of non-random X-inactivation.
  • There is no male-to-male transmission in the pedigree (but matings of an affected male and carrier female can give the appearance of male-to-male transmission.
A

X-linked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Somatic and germ line cells

A

Somatic cell mutations not passed on to children

Germ line cells may be.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Monosomy

A

One copy of chromosome
Monosomy X
Turners syndrome
Only females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Trisomy

A

Three copies of a chromosome
Trisomy 21 - downs syndrome
Trisomy 13 - Patau syndrome
Trisomy 18 - Edwards syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Triploidy

A

three sets of genetic material - no live births

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Nondisjunction

A

The abnormal distribution of chromosomes during meiosis ending up with double of nothing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mutation

A

A permanent change in DNA sequence.
Large scale: Chromosomal level) - gain/loss of chromosomal regions
Translocations of parts of a chromosome.
Small Scale Mutations: (DNA level)
Nucleotide base substitutions, deletions, or insertions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Missense mutation

A

result in an amino acid substitution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nonsense mutation

A

result in the premature addition of a stop codon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Frameshift mutation

A

result in an alteration of the reading frame, and thus an alteration to the amino acid sequence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Triplet repeat mutation

A

expand a critical area of a gene and subsequently alter the structure of a protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Point mutation

A

These are changes in single bases within the gene, they may or may not change the encoded amino acid and the effect is variable e.g. sickle cell disease and ABO blood groups are the result of point mutations. Many diseases are caused by point mutations and these are difficult to detect by molecular technologies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

NZ New Born screening program

A
Phenylketonuria (PKU)
Cystic Fibrosis (CF)
Biotinidase Deficiency
Congenital Adrenal Hyperplasia (CAH)
Galactosaemia
Hypothyroidism
Maple Syrup Urine Disease (MSUD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Prenatal tests

A

Give an estimate of the chance a disorder will occur
Identify women < 35 years old with higher risk pregnancies who can be offered diagnostic testing
Less invasive than diagnostic testing
Not a “Yes” or “No” answer
False +, False -

17
Q

Nuchal Translucency Screen

A

Ultrasound performed at 11-14 weeks gestation
Measurement of the thickness of the fluid that accumulates under the skin at the back of the neck
Increased Nuchal Translucency is associated with an increased chance of Down Syndrome
Maternal Age + Gestational Age + Nuchal Measurement into computer algorithm to produce an estimated risk for Down Syndrome

18
Q

Maternal Serum Screen

A

Maternal blood test at 15-17 weeks gestation
Measures the level of 3 proteins produced by the fetus & placenta
Maternal age + Protein levels are combined to produce an estimated risk for Chromosome Abnormalities and Neural Tube Defects
Not applicable for a diabetic mother, or a multiple pregnancy
Costs $75

19
Q

Detailed Prenatal Ultrasound

A

Both a screening test and a diagnostic test
Screening
◦Ultrasound findings which increase the chance that the fetus has a chromosome problem
◦e.g. shortened femur, nuchal oedema
Diagnosis
◦e.g. identification of Achondroplasia, NTD

20
Q

Prenatal Tests - Diagnostic

A

Give a clear answer (usually) about whether or not the fetus has a particular condition
Provide the most accurate results
Involve invasive procedures which carry a risk of miscarriage
Are only routinely offered to those at higher risk
e.g. women >35 yrs
women with an “increased risk” result on a screening test
significant family history

21
Q

Amniocentesis

A

Performed after 14 weeks of gestation
Karyotype from a sample of amniotic fluid
Identifies major chromosome anomalies
Does not identify gene mutations, very small chromosome changes, or structure and development of the fetus
Risk of miscarriage associated with the test is 1/200

22
Q

Chorionic Villus Sampling (CVS)

A

Performed between 10-12 weeks of gestation
Karyotype analysis from a sample of the placenta
Identifies major chromosome anomalies
Does not identify gene mutations, very small chromosome changes, or structure and development of the fetus
Risk of miscarriage associated with this test is 1/100

23
Q

Pregnancy screening results

A
Amniocentesis ~ 99.5% accurate
CVS ~ 96% accurate
Errors in result can arise from:
◦Culture failure
◦Maternal Cell Contamination
◦Mosaicism - sample has a mixture of normal and abnormal cells